By James Gallagher Health and science correspondent
Ten years' vaccine work achieved in about 10 months. Yet no corners cut in designing, testing and manufacturing.
They are two statements that sound like a contradiction, and have led some to ask how we can be sure the Oxford vaccine - which has published its first results showing it is highly effective at stopping Covid-19 - is safe when it has been made so fast.
So, this is the real story of how the Oxford vaccine happened so quickly.
It is one that relies on good fortune as well as scientific brilliance; has origins in both a deadly Ebola outbreak and a chimpanzee's runny nose; and sees the researchers go from having no money in the bank to chartering private planes.
The biggest misconception is the work on the vaccine started when the pandemic began.
The world's biggest Ebola outbreak in 2014-2016 was a catastrophe. The response was too slow and 11,000 people died.
"The world should have done better," Prof Sarah Gilbert, the architect of the Oxford vaccine, told me.
In the recriminations that followed, a plan emerged for how to tackle the next big one. At the end of a list of known threats was "Disease X" - the sinister name of a new, unknown infection that would take the world by surprise.
The Jenner Institute at the University of Oxford - named after the scientist that performed the first vaccination in 1796, and now home to some of the world's leading experts - designed a strategy for defeating an unknown enemy.
"We were planning how can we go really quickly to have a vaccine in someone in the shortest possible time," Prof Gilbert said.
"We hadn't got the plan finished, but we did do pretty well."
The central piece of their plan was a revolutionary style of vaccine known as "plug and play". It has two highly desirable traits for facing the unknown - it is both fast and flexible.
Conventional vaccines - including the whole of the childhood immunisation programme - use a killed or weakened form of the original infection, or inject fragments of it into the body. But these are slow to develop.
Instead the Oxford researchers constructed ChAdOx1 - or Chimpanzee Adenovirus Oxford One.
Scientists took a common cold virus that infected chimpanzees and engineered it to become the building block of a vaccine against almost anything.
Before Covid, 330 people had been given ChAdOx1 based-vaccines for diseases ranging from flu to Zika virus, and prostate cancer to the tropical disease chikungunya.
The virus from chimps is genetically modified so it cannot cause an infection in people. It can then be modified again to contain the genetic blueprints for whatever you want to train the immune system to attack. This target is known is an antigen.
ChAdOx1 is in essence a sophisticated, microscopic postman. All the scientists have to do is change the package.
tomcatty: Oxford vaccine: How did they make it so quickly?
By James Gallagher Health and science correspondent
Ten years' vaccine work achieved in about 10 months. Yet no corners cut in designing, testing and manufacturing.
They are two statements that sound like a contradiction, and have led some to ask how we can be sure the Oxford vaccine - which has published its first results showing it is highly effective at stopping Covid-19 - is safe when it has been made so fast.
So, this is the real story of how the Oxford vaccine happened so quickly.
It is one that relies on good fortune as well as scientific brilliance; has origins in both a deadly Ebola outbreak and a chimpanzee's runny nose; and sees the researchers go from having no money in the bank to chartering private planes.
The biggest misconception is the work on the vaccine started when the pandemic began.
The world's biggest Ebola outbreak in 2014-2016 was a catastrophe. The response was too slow and 11,000 people died.
"The world should have done better," Prof Sarah Gilbert, the architect of the Oxford vaccine, told me.
In the recriminations that followed, a plan emerged for how to tackle the next big one. At the end of a list of known threats was "Disease X" - the sinister name of a new, unknown infection that would take the world by surprise.
The Jenner Institute at the University of Oxford - named after the scientist that performed the first vaccination in 1796, and now home to some of the world's leading experts - designed a strategy for defeating an unknown enemy.
"We were planning how can we go really quickly to have a vaccine in someone in the shortest possible time," Prof Gilbert said.
"We hadn't got the plan finished, but we did do pretty well."
The central piece of their plan was a revolutionary style of vaccine known as "plug and play". It has two highly desirable traits for facing the unknown - it is both fast and flexible.
Conventional vaccines - including the whole of the childhood immunisation programme - use a killed or weakened form of the original infection, or inject fragments of it into the body. But these are slow to develop.
Instead the Oxford researchers constructed ChAdOx1 - or Chimpanzee Adenovirus Oxford One.
Scientists took a common cold virus that infected chimpanzees and engineered it to become the building block of a vaccine against almost anything.
Before Covid, 330 people had been given ChAdOx1 based-vaccines for diseases ranging from flu to Zika virus, and prostate cancer to the tropical disease chikungunya.
The virus from chimps is genetically modified so it cannot cause an infection in people. It can then be modified again to contain the genetic blueprints for whatever you want to train the immune system to attack. This target is known is an antigen.
ChAdOx1 is in essence a sophisticated, microscopic postman. All the scientists have to do is change the package.
"We drop it in and off we go," said Prof Gilbert.
While much of the world was having a lie-in after New Year's Eve, Prof Gilbert noticed concerning reports of "viral pneumonia" in Wuhan, China. Within two weeks scientists had identified the virus responsible and began to suspect it was able to spread between people.
"We'd been planning for disease X, we'd been waiting for disease X, and I thought this could be it," Prof Gilbert said.
At this point, the team did not know how important their work would become. It started out as a test of how fast they could go and as a demonstration of the ChAdOx1 technology.
Prof Gilbert said: "I thought it might only have been a project, we'd make the vaccine and the virus would fizzle out. But it didn't." A lucky break
It sounds strange to say it, almost perverse, but it was lucky that the pandemic was caused by a coronavirus.
This family of viruses had tried to jump from animals to people twice before in the past 20 years -
tomcatty: Are you joking Ali, it is a monumantal disovery, but should be kept from the Americans
There's an element of truth in Ali's post tom . I heard one of the research team saying something similar in an interview on R4 yesterday. He mentioned that research into the previous covid viruses had helped produce the vaccine.
DedovixBig Place, Central Serbia Serbia5,492 posts
tomcatty: Oxford vaccine: How did they make it so quickly?
.
Its quite easy, if you think of it it all started when a chinese guy ate a bat For the Vaccine -all they had to come up is a predatore who feeds on bats so in this case, they used a chinese who ate a weasel,
bodleing2: There's an element of truth in Ali's post tom . I heard one of the research team saying something similar in an interview on R4 yesterday. He mentioned that research into the previous covid viruses had helped produce the vaccine.
You obviously don't read peoples posts Bod, where it very learly states the history of the vaccine, and it's reliance on previous esearch, but this does not detract from the the veracity of the efficiency of the vaccine.
tomcatty: You obviously don't read peoples posts Bod, where it very clearly states the history of the vaccine, and it's reliance on previous esearch, but this does not detract from the the veracity of the efficiency of the vaccine.
bodleing2: There's an element of truth in Ali's post tom . I heard one of the research team saying something similar in an interview on R4 yesterday. He mentioned that research into the previous covid viruses had helped produce the vaccine.
Good morning everyone, and a very Happy Thanksgiving. I jumped into this thread because I’ve got a question ( I didn’t want to create a new thread unnecessarily) that ..sort of..goes here. Now, I’m not trying to start a debate at all- it’s just a question. Overall, in the United States, how many deaths were there in 2019? How many, so far, in 2020? How about globally? What I’m trying to find out is if the average yearly death rate would have been significantly less, and/ or if Covid, as bad as it is, is just another factor, such as pneumonia, influenza, accidental deaths, kidney failure, liver failure, heart failure, cancers, and so on. ( I may not be “ asking” google the right way, because I’m not getting any patent answer( s) there. Thanx...
rohaan: Good morning everyone, and a very Happy Thanksgiving. I jumped into this thread because I’ve got a question ( I didn’t want to create a new thread unnecessarily) that ..sort of..goes here. Now, I’m not trying to start a debate at all- it’s just a question. Overall, in the United States, how many deaths were there in 2019? How many, so far, in 2020? How about globally? What I’m trying to find out is if the average yearly death rate would have been significantly less, and/ or if Covid, as bad as it is, is just another factor, such as pneumonia, influenza, accidental deaths, kidney failure, liver failure, heart failure, cancers, and so on. ( I may not be “ asking” google the right way, because I’m not getting any patent answer( s) there. Thanx...
Report threads that break rules, are offensive, or contain fighting. Staff may not be aware of the forum abuse, and cannot do anything about it unless you tell us about it. click to report forum abuse »
If one of the comments is offensive, please report the comment instead (there is a link in each comment to report it).
By James Gallagher
Health and science correspondent
Ten years' vaccine work achieved in about 10 months. Yet no corners cut in designing, testing and manufacturing.
They are two statements that sound like a contradiction, and have led some to ask how we can be sure the Oxford vaccine - which has published its first results showing it is highly effective at stopping Covid-19 - is safe when it has been made so fast.
So, this is the real story of how the Oxford vaccine happened so quickly.
It is one that relies on good fortune as well as scientific brilliance; has origins in both a deadly Ebola outbreak and a chimpanzee's runny nose; and sees the researchers go from having no money in the bank to chartering private planes.
The biggest misconception is the work on the vaccine started when the pandemic began.
The world's biggest Ebola outbreak in 2014-2016 was a catastrophe. The response was too slow and 11,000 people died.
"The world should have done better," Prof Sarah Gilbert, the architect of the Oxford vaccine, told me.
In the recriminations that followed, a plan emerged for how to tackle the next big one. At the end of a list of known threats was "Disease X" - the sinister name of a new, unknown infection that would take the world by surprise.
The Jenner Institute at the University of Oxford - named after the scientist that performed the first vaccination in 1796, and now home to some of the world's leading experts - designed a strategy for defeating an unknown enemy.
"We were planning how can we go really quickly to have a vaccine in someone in the shortest possible time," Prof Gilbert said.
"We hadn't got the plan finished, but we did do pretty well."
The central piece of their plan was a revolutionary style of vaccine known as "plug and play". It has two highly desirable traits for facing the unknown - it is both fast and flexible.
Conventional vaccines - including the whole of the childhood immunisation programme - use a killed or weakened form of the original infection, or inject fragments of it into the body. But these are slow to develop.
Instead the Oxford researchers constructed ChAdOx1 - or Chimpanzee Adenovirus Oxford One.
Scientists took a common cold virus that infected chimpanzees and engineered it to become the building block of a vaccine against almost anything.
Before Covid, 330 people had been given ChAdOx1 based-vaccines for diseases ranging from flu to Zika virus, and prostate cancer to the tropical disease chikungunya.
The virus from chimps is genetically modified so it cannot cause an infection in people. It can then be modified again to contain the genetic blueprints for whatever you want to train the immune system to attack. This target is known is an antigen.
ChAdOx1 is in essence a sophisticated, microscopic postman. All the scientists have to do is change the package.
"We drop it in and off we go," said Prof Gilbert.